TRINITY BIOTECH, PLC
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
Devices registered here (1)
- Radioassay, Angiotensin Converting EnzymeProduct code KQN (opens in a new tab) · Class II · Clinical Chemistry · 21 CFR 862.1090
Recalls & enforcement
- Class IIOngoing2025-07-22Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter.
Related
- All facilities operated by TRINITY BIOTECH, PLC
- Trinity Biotech USA (NY)
- Trinity Biotech do Brasil (BR)
- Trinity Biotech (Primus Corporation dba Trinity Biotech) (MO)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “TRINITY BIOTECH, PLC (FEI 3002546385) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3002546385-trinity-biotech-plc/
Alerts for TRINITY BIOTECH, PLC
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.